Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005 (scientific article published on 29 April 2009)

Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin

Q34721715

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

Q34783668

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

Q34910366

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

Q36328966

Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period

Q41066970

Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.

Q41915074

Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci

Q42637617

Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used

Q43202070

Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate

Q43778948

Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus

Q44755051

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

Q46431265

Three-year surveillance of community-acquired Staphylococcus aureus infections in children

Q46503394

Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage

Q46541443

Point: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus

Q80363319

Counterpoint: Vancomycin and Staphylococcus aureus--an antibiotic enters obsolescence

Q80363323

Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05

Q80595494

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

Staphylococcus aureus

Q188121

vancomycin

Q424027

P304

page(s)

1628-1630

P577

publication date

2009-04-29

P1433

published in

Journal of Clinical Microbiology

Q4041880

P1476

title

Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005

P478

volume

Reverse relations

cites work (P2860)

Q51137323	27th Annual Meeting of the European Society for Paediatric Infectious Diseases.
Q54257521	Association of Vancomycin MIC and Molecular Characteristics with Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children.
Q35055669	Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity.
Q36171683	Comparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection model
Q42855424	Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies
Q46558220	Correlation of methicillin-resistant Staphylococcus aureus vancomycin minimal inhibitory concentration results by Etest and broth microdilution methods with population analysis profile: lack of Etest overestimation of the MIC.
Q42085132	Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus
Q37125081	Effects of aggregate and individual antibiotic exposure on vancomycin MICs for Staphylococcus aureus isolates recovered from pediatric patients
Q39340850	Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children
Q41258576	Evaluating vancomycin susceptibility in Staphylococcus aureus
Q36576652	Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome
Q42929172	Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results
Q40914477	Methicillin Resistant Staphylococcus aureus: Inconsistencies in Vancomycin Susceptibility Testing Methods, Limitations and Advantages of each Method
Q36169980	No evidence of vancomycin minimal inhibitory concentration creep or heteroresistance identified in pediatric Staphylococcus aureus blood isolates
Q39411995	Novel screening agar for detection of vancomycin-nonsusceptible Staphylococcus aureus
Q36981191	Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range.
Q37356506	Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.
Q33806504	Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia
Q42572435	Reduced susceptibility to vancomycin in Staphylococcus aureus
Q61814412	Vancomycin MIC Distribution among Methicillin-Resistant . Is Reduced Vancomycin Susceptibility Related To MIC Creep?
Q41428954	Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus isolates: evaluation of the broth microdilution and Etest methods.
Q48575528	Vancomycin MICs of the resistant mutants of S. aureus ATCC43300 vary based on the susceptibility test methods used
Q38462842	Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice
Q38993110	Vancomycin minimum inhibitory concentrations and lethality in Staphylococcus aureus bacteremia